John Y. Televantos's most recent trade in Balchem Corp. was a trade of 258 Common Stock done at an average price of $135.7 . Disclosure was reported to the exchange on Feb. 13, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Balchem Corp. | John Y. Televantos | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.67 per share. | 13 Feb 2023 | 258 | 29,078 (0%) | 0% | 135.7 | 35,003 | Common Stock |
Balchem Corp. | John Y. Televantos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 1,790 | 1,790 | - | - | Stock Option | |
Balchem Corp. | John Y. Televantos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 530 | 29,336 (0%) | 0% | 0 | Common Stock | |
Balchem Corp. | John Y. Televantos | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.38 per share. | 15 Feb 2022 | 359 | 28,806 (0%) | 0% | 139.4 | 50,037 | Common Stock |
Balchem Corp. | John Y. Televantos | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.73 per share. | 14 Feb 2022 | 331 | 29,165 (0%) | 0% | 137.7 | 45,589 | Common Stock |
Balchem Corp. | John Y. Televantos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,747 | 13,787 | - | - | Stock Option | |
Balchem Corp. | John Y. Televantos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 509 | 29,496 (0%) | 0% | 0 | Common Stock | |
Balchem Corp. | John Y. Televantos | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.57 per share. | 22 Feb 2021 | 548 | 28,987 (0%) | 0% | 121.6 | 66,620 | Common Stock |
Balchem Corp. | John Y. Televantos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,124 | 12,040 | - | - | Stock Option | |
Balchem Corp. | John Y. Televantos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 590 | 29,535 (0%) | 0% | 0 | Common Stock |